GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call
GoodRx, the leading platform for medication savings in the U.S., has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results after U.S. markets close on Wednesday, May 7, 2025.
A conference call and webcast with GoodRx management will follow on Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and business outlook. Interested parties can pre-register for the conference call through a provided link to receive dial-in details and a unique passcode.
The call will be webcast live on the company's investor relations website, where presentation materials will be available before the conference. An archived version of the webcast will remain accessible for at least 30 days after the call.
GoodRx, la principale piattaforma per il risparmio sui farmaci negli Stati Uniti, ha programmato l'annuncio dei risultati finanziari del primo trimestre del 2025. L'azienda pubblicherà i risultati del Q1 2025 dopo la chiusura dei mercati statunitensi il mercoledì 7 maggio 2025.
Una conferenza telefonica e un webcast con il management di GoodRx seguiranno il giovedì 8 maggio 2025 alle 5:00 ora del Pacifico (8:00 ora dell'Est) per discutere i risultati e le prospettive aziendali. Le parti interessate possono preregistrarsi per la conferenza telefonica tramite un link fornito per ricevere i dettagli di accesso e un codice di accesso unico.
La chiamata sarà trasmessa in diretta sul sito web delle relazioni con gli investitori dell'azienda, dove saranno disponibili i materiali della presentazione prima della conferenza. Una versione archiviata del webcast rimarrà accessibile per almeno 30 giorni dopo la chiamata.
GoodRx, la plataforma líder en ahorros de medicamentos en EE. UU., ha programado el anuncio de sus resultados financieros del primer trimestre de 2025. La compañía publicará sus resultados del Q1 2025 después del cierre de los mercados estadounidenses el miércoles 7 de mayo de 2025.
Una conferencia telefónica y un webcast con la dirección de GoodRx seguirá el jueves 8 de mayo de 2025 a las 5:00 a.m. hora del Pacífico (8:00 a.m. hora del Este) para discutir los resultados y las perspectivas comerciales. Las partes interesadas pueden preinscribirse para la conferencia telefónica a través de un enlace proporcionado para recibir detalles de acceso y un código de acceso único.
La llamada se transmitirá en vivo en el sitio web de relaciones con inversores de la empresa, donde los materiales de presentación estarán disponibles antes de la conferencia. Una versión archivada del webcast permanecerá accesible durante al menos 30 días después de la llamada.
GoodRx, 미국에서 약품 절약을 위한 선도적인 플랫폼, 2025년 1분기 재무 결과 발표를 예정하고 있습니다. 회사는 2025년 5월 7일 수요일 미국 시장이 마감된 후 Q1 2025 결과를 발표할 것입니다.
GoodRx 경영진과의 전화 회의 및 웹캐스트는 2025년 5월 8일 목요일 오전 5:00 태평양 표준시(동부 표준시 오전 8:00)에 결과 및 사업 전망에 대해 논의하기 위해 진행됩니다. 관심 있는 분들은 제공된 링크를 통해 전화 회의에 사전 등록하여 접속 세부정보와 고유 패스코드를 받을 수 있습니다.
이 통화는 회사의 투자자 관계 웹사이트에서 실시간으로 방송되며, 회의 전에 발표 자료가 제공됩니다. 통화 후 최소 30일 동안 아카이브된 웹캐스트 버전이 접근 가능합니다.
GoodRx, la principale plateforme d'économies sur les médicaments aux États-Unis, a programmé l'annonce de ses résultats financiers pour le premier trimestre 2025. L'entreprise publiera ses résultats du Q1 2025 après la fermeture des marchés américains le mercredi 7 mai 2025.
Une conférence téléphonique et un webcast avec la direction de GoodRx suivront le jeudi 8 mai 2025 à 5h00 heure du Pacifique (8h00 heure de l'Est) pour discuter des résultats et des perspectives commerciales. Les parties intéressées peuvent se préinscrire à la conférence téléphonique via un lien fourni pour recevoir les détails d'appel et un code d'accès unique.
La conférence sera diffusée en direct sur le site web des relations avec les investisseurs de l'entreprise, où les documents de présentation seront disponibles avant la conférence. Une version archivée du webcast restera accessible pendant au moins 30 jours après l'appel.
GoodRx, die führende Plattform für Medikamenteneinsparungen in den USA, hat die Bekanntgabe ihrer finanziellen Ergebnisse für das erste Quartal 2025 angesetzt. Das Unternehmen wird seine Q1 2025 Ergebnisse nach dem Schließen der US-Märkte am Mittwoch, den 7. Mai 2025 veröffentlichen.
Ein Konferenzgespräch und ein Webcast mit dem Management von GoodRx folgen am Donnerstag, den 8. Mai 2025 um 5:00 Uhr Pazifischer Zeit (8:00 Uhr Eastern Time), um die Ergebnisse und die Geschäftsaussichten zu erörtern. Interessierte Parteien können sich über einen bereitgestellten Link für das Konferenzgespräch vorregistrieren, um Einwahldetails und einen einzigartigen Zugangscode zu erhalten.
Das Gespräch wird live auf der Investor-Relations-Website des Unternehmens übertragen, wo die Präsentationsmaterialien vor der Konferenz verfügbar sein werden. Eine archivierte Version des Webcasts bleibt mindestens 30 Tage nach dem Gespräch zugänglich.
- None.
- None.
To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.
Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.
About GoodRx
GoodRx is the leading platform for medication savings in the
GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409741987/en/
Investor Contact
GoodRx
Aubrey Reynolds
ir@goodrx.com
Media Contact
GoodRx
Lauren Casparis
lcasparis@goodrx.com
Source: GoodRx Holdings, Inc.
FAQ
When will GoodRx (GDRX) release its Q1 2025 earnings?
What time is the GoodRx (GDRX) Q1 2025 earnings call?
How can investors access the GoodRx (GDRX) Q1 2025 earnings call?
How long will the GoodRx (GDRX) Q1 2025 earnings webcast be available?
